Cargando…
Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway
Acquired heterotopic ossification (HO) is the extraskeletal bone formation after trauma. Various mesenchymal progenitors are reported to participate in ectopic bone formation. Here we induce acquired HO in mice by Achilles tenotomy and observe that conditional knockout (cKO) of fibroblast growth fac...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289847/ https://www.ncbi.nlm.nih.gov/pubmed/34282140 http://dx.doi.org/10.1038/s41467-021-24643-2 |
_version_ | 1783724377310756864 |
---|---|
author | Zhang, Dali Huang, Junlan Sun, Xianding Chen, Hangang Huang, Shuo Yang, Jing Du, Xiaolan Tan, Qiaoyan Luo, Fengtao Zhang, Ruobin Zhou, Siru Jiang, Wanling Ni, Zhenhong Wang, Zuqiang Jin, Min Xu, Meng Li, Fangfang Chen, Liang Liu, Mi Su, Nan Luo, Xiaoqing Yin, Liangjun Zhu, Ying Feng, Jerry Q. Chen, Di Qi, Huabing Chen, Lin Xie, Yangli |
author_facet | Zhang, Dali Huang, Junlan Sun, Xianding Chen, Hangang Huang, Shuo Yang, Jing Du, Xiaolan Tan, Qiaoyan Luo, Fengtao Zhang, Ruobin Zhou, Siru Jiang, Wanling Ni, Zhenhong Wang, Zuqiang Jin, Min Xu, Meng Li, Fangfang Chen, Liang Liu, Mi Su, Nan Luo, Xiaoqing Yin, Liangjun Zhu, Ying Feng, Jerry Q. Chen, Di Qi, Huabing Chen, Lin Xie, Yangli |
author_sort | Zhang, Dali |
collection | PubMed |
description | Acquired heterotopic ossification (HO) is the extraskeletal bone formation after trauma. Various mesenchymal progenitors are reported to participate in ectopic bone formation. Here we induce acquired HO in mice by Achilles tenotomy and observe that conditional knockout (cKO) of fibroblast growth factor receptor 3 (FGFR3) in Col2(+) cells promote acquired HO development. Lineage tracing studies reveal that Col2(+) cells adopt fate of lymphatic endothelial cells (LECs) instead of chondrocytes or osteoblasts during HO development. FGFR3 cKO in Prox1(+) LECs causes even more aggravated HO formation. We further demonstrate that FGFR3 deficiency in LECs leads to decreased local lymphatic formation in a BMPR1a-pSmad1/5-dependent manner, which exacerbates inflammatory levels in the repaired tendon. Local administration of FGF9 in Matrigel inhibits heterotopic bone formation, which is dependent on FGFR3 expression in LECs. Here we uncover Col2(+) lineage cells as an origin of lymphatic endothelium, which regulates local inflammatory microenvironment after trauma and thus influences HO development via FGFR3-BMPR1a pathway. Activation of FGFR3 in LECs may be a therapeutic strategy to inhibit acquired HO formation via increasing local lymphangiogenesis. |
format | Online Article Text |
id | pubmed-8289847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82898472021-07-23 Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway Zhang, Dali Huang, Junlan Sun, Xianding Chen, Hangang Huang, Shuo Yang, Jing Du, Xiaolan Tan, Qiaoyan Luo, Fengtao Zhang, Ruobin Zhou, Siru Jiang, Wanling Ni, Zhenhong Wang, Zuqiang Jin, Min Xu, Meng Li, Fangfang Chen, Liang Liu, Mi Su, Nan Luo, Xiaoqing Yin, Liangjun Zhu, Ying Feng, Jerry Q. Chen, Di Qi, Huabing Chen, Lin Xie, Yangli Nat Commun Article Acquired heterotopic ossification (HO) is the extraskeletal bone formation after trauma. Various mesenchymal progenitors are reported to participate in ectopic bone formation. Here we induce acquired HO in mice by Achilles tenotomy and observe that conditional knockout (cKO) of fibroblast growth factor receptor 3 (FGFR3) in Col2(+) cells promote acquired HO development. Lineage tracing studies reveal that Col2(+) cells adopt fate of lymphatic endothelial cells (LECs) instead of chondrocytes or osteoblasts during HO development. FGFR3 cKO in Prox1(+) LECs causes even more aggravated HO formation. We further demonstrate that FGFR3 deficiency in LECs leads to decreased local lymphatic formation in a BMPR1a-pSmad1/5-dependent manner, which exacerbates inflammatory levels in the repaired tendon. Local administration of FGF9 in Matrigel inhibits heterotopic bone formation, which is dependent on FGFR3 expression in LECs. Here we uncover Col2(+) lineage cells as an origin of lymphatic endothelium, which regulates local inflammatory microenvironment after trauma and thus influences HO development via FGFR3-BMPR1a pathway. Activation of FGFR3 in LECs may be a therapeutic strategy to inhibit acquired HO formation via increasing local lymphangiogenesis. Nature Publishing Group UK 2021-07-19 /pmc/articles/PMC8289847/ /pubmed/34282140 http://dx.doi.org/10.1038/s41467-021-24643-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zhang, Dali Huang, Junlan Sun, Xianding Chen, Hangang Huang, Shuo Yang, Jing Du, Xiaolan Tan, Qiaoyan Luo, Fengtao Zhang, Ruobin Zhou, Siru Jiang, Wanling Ni, Zhenhong Wang, Zuqiang Jin, Min Xu, Meng Li, Fangfang Chen, Liang Liu, Mi Su, Nan Luo, Xiaoqing Yin, Liangjun Zhu, Ying Feng, Jerry Q. Chen, Di Qi, Huabing Chen, Lin Xie, Yangli Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway |
title | Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway |
title_full | Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway |
title_fullStr | Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway |
title_full_unstemmed | Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway |
title_short | Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway |
title_sort | targeting local lymphatics to ameliorate heterotopic ossification via fgfr3-bmpr1a pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289847/ https://www.ncbi.nlm.nih.gov/pubmed/34282140 http://dx.doi.org/10.1038/s41467-021-24643-2 |
work_keys_str_mv | AT zhangdali targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT huangjunlan targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT sunxianding targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT chenhangang targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT huangshuo targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT yangjing targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT duxiaolan targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT tanqiaoyan targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT luofengtao targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT zhangruobin targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT zhousiru targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT jiangwanling targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT nizhenhong targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT wangzuqiang targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT jinmin targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT xumeng targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT lifangfang targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT chenliang targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT liumi targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT sunan targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT luoxiaoqing targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT yinliangjun targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT zhuying targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT fengjerryq targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT chendi targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT qihuabing targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT chenlin targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway AT xieyangli targetinglocallymphaticstoameliorateheterotopicossificationviafgfr3bmpr1apathway |